Key1 Capital

Activity from announced rounds

Activity in this selectionvictoria-treyger-f54c261b
Rounds participated in
3
Confirmed lead rounds
—
3 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$143M
2 disclosed · full round size, not this investor’s share

By stage

Growth1
Series A1
Undisclosed1

By primary sector

AI1
Biotech1
Hardware1

By country

United States2
Israel1

Rounds

3 in this selection
Remepy

Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps

$36MSeries A
Role not disclosed
Xsight Labs

Fabless semiconductor company building connectivity chips for hyperscale, edge, and AI data centers

>$300MGrowth
Role not disclosed
Lyte

Builds perception systems for Physical AI operating in complex environments

$107MUndisclosed
Role not disclosed